ST Pharm Co.,Ltd. (KOSDAQ:237690)

ST Pharm Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 16, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,558,728	1,790,029	1,275,235	1,647,649	2,596,915	1,936,493
Market Cap Growth	42.30%	40.37%	-22.60%	-36.55%	34.10%	248.32%
Enterprise Value	2,518,704	1,811,053	1,375,695	1,714,024	2,628,966	1,910,417
Last Close Price	123600.00	88900.00	67410.34	86388.45	136510.46	101442.21
PE Ratio	68.85	51.57	65.13	91.54	784.06	-
Forward PE	41.35	36.22	37.69	67.19	133.19	-
PS Ratio	8.04	6.54	4.47	6.61	15.68	15.60
PB Ratio	4.60	3.56	3.30	4.83	7.97	6.53
P/TBV Ratio	4.74	3.68	3.44	5.07	8.37	6.79
P/FCF Ratio	170.55	67.18	-	-	-	-
P/OCF Ratio	28.15	16.36	982.17	234.34	357.22	-
EV/Sales Ratio	7.91	6.62	4.83	6.88	15.87	15.39
EV/EBITDA Ratio	31.78	33.99	24.33	48.35	131.50	-
EV/EBIT Ratio	49.19	65.40	41.05	96.02	471.35	-
EV/FCF Ratio	167.88	67.97	-	-	-	-
Debt / Equity Ratio	0.14	0.24	0.50	0.39	0.33	0.43
Debt / EBITDA Ratio	1.01	2.22	3.40	3.79	5.38	-
Debt / FCF Ratio	5.33	4.43	-	-	-	-
Asset Turnover	0.44	0.39	0.46	0.47	0.35	0.32
Inventory Turnover	1.16	1.46	1.54	1.72	1.75	2.45
Quick Ratio	0.96	1.43	2.53	0.82	3.00	10.07
Current Ratio	2.04	2.48	4.16	1.47	4.64	12.66
Return on Equity (ROE)	6.89%	7.30%	4.81%	5.25%	1.08%	-4.38%
Return on Assets (ROA)	4.44%	2.48%	3.36%	2.09%	0.74%	-2.99%
Return on Invested Capital (ROIC)	5.16%	2.88%	3.97%	2.45%	0.81%	-3.17%
Return on Capital Employed (ROCE)	8.90%	4.70%	5.70%	4.60%	1.30%	-4.40%
Earnings Yield	1.44%	1.94%	1.54%	1.09%	0.13%	-0.63%
FCF Yield	0.59%	1.49%	-3.29%	-3.24%	-1.71%	-1.96%
Dividend Yield	0.41%	0.56%	-	-	-	-
Payout Ratio	27.31%	27.09%	48.03%	52.25%	-	-
Buyback Yield / Dilution	-7.23%	-3.70%	-	-0.77%	-0.05%	-
Total Shareholder Return	-6.82%	-3.13%	-	-0.77%	-0.05%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.